Sabinsa, the multi-national health science company founded by Dr. Muhammed Majeed 35 years ago, will begin the new year by relocating the Sabinsa Nanjing Biotechnology Company Limited corporate office to a  new location in Nanjing, China. In addition to office space, the company will have a sizeable warehouse, repacking, QC, and meeting rooms on the premises. 

The new location features modern interiors that bring a vibrant and positive atmosphere to the  workplace. The spacious, open, and comfortable work environment presents an ideal setting for the dynamic Chinese team to deliver best-in-class service to further support its customers. The Sabinsa Nanjing Biotechnology Company Limited staff is led by Ms. Julia Wei, President.

“With great pride, we unveil our new office in China, signifying our commitment to growth in this promising market and providing our valued customers with enhanced service,” said Dr. Muhammed Majeed, Founder and Group Chairman, Sami-Sabinsa Group. “The workspace is officially open, and the team is happy to host its customers and partners to continue the successful journey together.”

“With a presence in 17 countries, the Sami-Sabinsa Group has grown its total global workforce to over 1400 employees. Recently, the Group’s presence in Europe has been expanded, with new satellite offices in the UK, Spain, France, and Hungary, in addition to its existing offices in Germany and Poland,” added Mr. Madhu Subramanian, President of Global Business Expansion and Operations.

Sabinsa Nanjing Biotechnology Company Limited staff from left to right Ms. Julia Wei (President), Ms. Maggie Wang (Tech Sales Manager), Ms. Annie Wang (Procuring & Logistic Manager),  Mr. Jason Li (Sales Director).

About Sabinsa

Sabinsa, founded in 1988, is a manufacturer and supplier of standardized herbal extracts, nutraceutical and cosmeceutical ingredients, probiotics, minerals, enzymes, and specialty and fine chemicals. The company markets over  120 standardized botanical extracts and employs more than  1,400 people worldwide in  27 manufacturing, R&D, sales, and distribution facilities. Process development and product innovation form the focus of the ongoing R&D efforts in the company’s research facilities, located in India and the U.S. Products, many of which are both Kosher and Halal, are extensively researched, patented, and supported by hundreds of published clinical studies. Sabinsa’s botanical cultivation program totals nearly  20,000 acres to ensure sustainable, fair-trade materials are used in these ingredients. For more information, visit sabinsa.com or Sabinsa.eu.